Century Pharmaceuticals Ltd

NCT01776515

Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients

NCT01776697

Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects

NCT01589562

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

NCT01606059

Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition

NCT02071381

Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

NCT02380976

Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers

NCT02933658

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

NCT04228406

Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161

NCT05155072

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

NCT04386915

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

NCT05214690

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

NCT05214677

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

NCT04499443

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

NCT04868981

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

NCT05345964

Phase I Study of GST-HG151 Tablets in Healthy Volunteers

NCT05381870

Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

NCT06147908

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

NCT05468645

In Vivo Mass Balance Study of [14C]Hemay005

NCT06368960

BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors

NCT05749432

A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors

NCT06462716

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

NCT05941247

A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers

NCT06433726

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

NCT06731699

A Phase 1 Study of FD-001 in Recurrent /Refractory (R/R)AML/NHL/MM/MDS

NCT06376474

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

NCT06380153

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

NCT06610903

Bioequivalence Test of Hemay005 Tablets

NCT06610890

Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets

NCT06908642

Evaluation the Safety of hemay005 Tablets

NCT07032558

Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions

NCT07060209

Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults